These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34281844)

  • 41. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W; Liu Q; Jiang N; Li M; Shi L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
    Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
    Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
    Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
    Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway.
    Hakimee H; Hutamekalin P; Tanasawet S; Chonpathompikunlert P; Tipmanee V; Sukketsiri W
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3539-3545. PubMed ID: 31870092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells.
    Hernández AJA; Reyes VL; Albores-García D; Gómez R; Calderón-Aranda ES
    Toxicology; 2018 Feb; 394():35-44. PubMed ID: 29197552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation.
    Cheng XD; Gu JF; Yuan JR; Feng L; Jia XB
    Mol Med Rep; 2015 Dec; 12(6):7992-8002. PubMed ID: 26498639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
    Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
    Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
    Huang Q; Shen HM; Ong CN
    Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5'-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling.
    Kim SA; Kwon SM; Kim JA; Kang KW; Yoon JH; Ahn SG
    Cancer Lett; 2011 Jul; 306(2):197-204. PubMed ID: 21463917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
    Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
    Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
    J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells.
    Yu H; Gao M; Ma Y; Wang L; Shen Y; Liu X
    Int J Mol Med; 2018 May; 41(5):2573-2588. PubMed ID: 29484384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway.
    Masraksa W; Tanasawet S; Hutamekalin P; Wongtawatchai T; Sukketsiri W
    Nutr Res Pract; 2020 Apr; 14(2):127-133. PubMed ID: 32256987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moscatilin inhibits lung cancer cell motility and invasion via suppression of endogenous reactive oxygen species.
    Kowitdamrong A; Chanvorachote P; Sritularak B; Pongrakhananon V
    Biomed Res Int; 2013; 2013():765894. PubMed ID: 23738332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendrofalconerol A sensitizes anoikis and inhibits migration in lung cancer cells.
    Pengpaeng P; Sritularak B; Chanvorachote P
    J Nat Med; 2015 Apr; 69(2):178-90. PubMed ID: 25391454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.
    Wei L; Yao Y; Zhao K; Huang Y; Zhou Y; Zhao L; Guo Q; Lu N
    Mol Carcinog; 2016 Dec; 55(12):2121-2134. PubMed ID: 26741501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alisol B 23‑acetate inhibits the viability and induces apoptosis of non‑small cell lung cancer cells via PI3K/AKT/mTOR signal pathway.
    Liu Y; Xia XC; Meng LY; Wang Y; Li YM
    Mol Med Rep; 2019 Aug; 20(2):1187-1195. PubMed ID: 31173235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling.
    Lin CH; Lin HH; Kuo CY; Kao SH
    Oncotarget; 2017 Feb; 8(7):11316-11328. PubMed ID: 28076322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
    Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
    Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.